THE DENTAL AWARDS 2025 – REGISTER NOW!

A non-invasive option for early detection

Featured Products Promotional Features

  Posted by: Dental Design      19th December 2023

Tests to assist in the diagnosis of oral cancer can be invasive, and sometimes inappropriate for detecting cancer in its early stages. Saliva tests can be an effective, non-invasive pre-diagnostic tool.

The BeVigilant™ OraFusion™ System from Vigilant Biosciences® is a non-invasive fluoroscopic and visual saliva biomarker-based semi-quantitative risk assessment tool which is intended to be used during examination, without the use of a tissue biopsy. In 15 minutes or less, the BeVigilant™ OraFusion™ System easily identifies the presence of biomarkers associated with oral cancer and produces a report of either low, moderate, or elevated risk levels to assist dentists in their decision making.

To discover more about this pre-diagnostic testing system, please visit the website or get in touch today.

For more information, please visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com


Join our
Mailing List

Sign up to our newsletter and keep up to date on the latest happenings in the dental market.

Sign up today